{"id":57951,"date":"2024-08-05T12:03:55","date_gmt":"2024-08-05T12:03:55","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/08\/05\/loreal-groupe-acquires-a-10-stake-in-galderma-the-pure-play-dermatology-leader-and-one-of-the-worlds-largest-players-in-injectable-aesthetics\/"},"modified":"2024-08-05T12:03:55","modified_gmt":"2024-08-05T12:03:55","slug":"loreal-groupe-acquires-a-10-stake-in-galderma-the-pure-play-dermatology-leader-and-one-of-the-worlds-largest-players-in-injectable-aesthetics","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/loreal-groupe-acquires-a-10-stake-in-galderma-the-pure-play-dermatology-leader-and-one-of-the-worlds-largest-players-in-injectable-aesthetics\/","title":{"rendered":"L\u2019Or\u00e9al Groupe acquires a 10% stake in Galderma, the pure-play dermatology leader and one of the world\u2019s largest players in injectable aesthetics"},"content":{"rendered":"
\n

THIS INVESTMENT TO BE COMPLEMENTED BY A NEW STRATEGIC SCIENTIFIC PARTNERSHIP\u00a0<\/em>
BETWEEN L\u2019OR\u00c9AL AND GALDERMA.<\/em><\/strong><\/p>\n

\u00a0<\/p>\n

Clichy, August 5th, 2024 –\u00a0<\/strong>L\u2019Or\u00e9al today announces the acquisition of a 10% stake in Galderma Group AG from Sunshine SwissCo AG (a consortium led by EQT), Abu Dhabi Investment Authority (ADIA), Auba Investment Pte. Ltd. (all acting in coordination as sellers), for a non-disclosed amount.<\/p>\n

In addition, L\u2019Or\u00e9al and Galderma have agreed to work towards a strategic scientific partnership that will leverage the undisputed expertise of both companies: Galderma\u2019s across a broad range of dermatological solutions, and L\u2019Or\u00e9al\u2019s expertise in skin biology, diagnostic tools and evaluation methods.<\/p>\n

\u201cI am very pleased to announce this strategic investment and partnership with Galderma. It marks an ambitious step for L\u2019Or\u00e9al, and true to our mantra of \u2018seize what is starting,\u2019 it allows us to explore partnering in the fast-growing aesthetics market, a key adjacency to our own pure beauty play<\/em>\u201d said Nicolas Hieronimus, Chief Executive Officer of L\u2019OREAL<\/strong>. \u201cWe fully support Galderma\u2019s management and its strategy as a leading dermatology pure player, respect its independence and are very confident in its long-term growth potential<\/em>.\u201d\u00a0<\/p>\n

As the world leader in Beauty and forerunner in Beauty Tech, L\u2019Or\u00e9al is increasingly investing in a more holistic approach, spanning the entire beauty routine. This approach aims to blend diagnostic tools, high-performance topical products, consumer devices, and aesthetic treatments, to deliver new combined levels of performance, by correcting, repairing, preventing, anticipating, and intercepting the signs of skin ageing.<\/p>\n

L\u2019Or\u00e9al\u2019s strategic investment in Galderma confirms the solid growth journey that the company has embarked on over the past decade. Under the successful leadership of Flemming \u00d8rnskov, M.D., MPH, Chief Executive Officer of Galderma, with the support of the EQT-led consortium, Galderma has established itself as the pure-play dermatology category leader and one of the world\u2019s largest players in injectable aesthetics. Today, Galderma offers a broad portfolio of dermo-cosmetics, dermatologic drugs, and best-in-class hyaluronic acid (HA) fillers, neuromodulators and biostimulators.<\/p>\n

Galderma is fully supportive of the transaction and of the strategic scientific partnership and welcomes L\u2019Or\u00e9al as a strong long-term partner.<\/p>\n

L\u2019Or\u00e9al will not seek to be represented at Galderma\u2019s Board of Directors and has agreed to customary provisions for an investment of this type as part of a shareholders\u2019 agreement entered into with Sunshine SwissCo AG.<\/p>\n

The transaction will be implemented by way of an off-market block trade with the EQT-led consortium. L\u2019Or\u00e9al and the EQT-led consortium do not intend to act in concert.<\/p>\n

The transaction will be funded with L\u2019Or\u00e9al\u2019s available cash and credit lines, and closing is expected to be completed in the coming days.<\/p>\n

An investor call led by Nicolas Hieronimus and Christophe Babule, Chief Financial Officer of L\u2019Or\u00e9al will be organized on Monday 5th August at 10 a.m (Paris time, UTC+2)<\/em><\/p>\n

\u00a0<\/p>\n\n\n\n\n\n
Conf\u00e9rence call access\u00a0<\/td>\nL\u2019Or\u00e9al \u2013 Conference call<\/td>\n<\/tr>\n
Num\u00e9ro participants FR\u00a0:<\/td>\n+33 0170918704<\/td>\n<\/tr>\n
Num\u00e9ro participants US\u00a0:\u00a0<\/td>\n+1 718 7058796<\/td>\n<\/tr>\n
Num\u00e9ro participants UK\u00a0:<\/td>\n+44 1 212818004<\/td>\n<\/tr>\n<\/table>\n

\u00a0<\/p>\n

\u201cThis news release does not constitute an offer to sell, or a solicitation of an offer to buy L\u2019Or\u00e9al shares. If you wish to obtain more comprehensive information about L\u2019Or\u00e9al, please refer to the public documents registered in France with the Autorit\u00e9 des March\u00e9s Financiers, also available in English on our website<\/em>www.loreal-finance.com<\/a>.<\/p>\n

This news release may contain some forward-looking statements. While the Company believes that these statements are based on reasonable assumptions as of the date of publication of this press release, they are by nature subject to risks and uncertainties which may lead to a discrepancy between the actual figures and those indicated or suggested in these statements.\u201d<\/em><\/p>\n

About L\u2019Or\u00e9al Groupe<\/strong><\/em><\/p>\n

For 115 years, L\u2019Or\u00e9al, the world\u2019s leading beauty player, has devoted itself to one thing only: fulfilling the beauty aspirations of consumers around the world. Our purpose, to create the beauty that moves the world, defines our approach to beauty as essential, inclusive, ethical, generous and committed to social and environmental sustainability. With our broad portfolio of 37 international brands and ambitious sustainability commitments in our L\u2019Or\u00e9al for the Future programme, we offer each and every person around the world the best in terms of quality, efficacy, safety, sincerity and responsibility, while celebrating beauty in its infinite plurality.<\/em><\/p>\n

With more than 90,000 committed employees, a balanced geographical footprint and sales across all distribution networks (e-commerce, mass market, department stores, pharmacies,perfumeries, hair salons, branded and travel retail), in 2023 the Group generated sales amounting to 41.18 billion euros.<\/strong> With 20 research centers across 11 countries around the world and a dedicated Research and Innovation team of over 4,000 scientists and 6,400 Digital talents, L\u2019Or\u00e9al is focused on inventing the future of beauty and becoming a Beauty Tech powerhouse.<\/em><\/p>\n

More information on <\/em>https:\/\/www.loreal.com\/en\/mediaroom<\/em><\/a><\/p>\n

About Galderma<\/strong><\/em>
Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body\u2019s largest organ \u2013 the skin \u2013 meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.<\/em><\/p>\n

\u00a0<\/p>\n

L\u2019OR\u00c9AL CONTACTS<\/strong><\/p>\n

Switchboard<\/strong>
+33 (0) 1 47 56 70 00
Individual shareholders and market authorities<\/strong>
Pascale Guerin<\/strong><\/em><\/em>
+33 (0)1 49 64 18 89
pascale.guerin@loreal.com
Investor relations<\/strong>
Eva Quiroga<\/strong><\/em><\/em>
+33 (0)7 88 14 22 65
eva.quiroga@loreal.com
Journalists<\/strong>
Brune Diricq<\/strong><\/em><\/em>
+33 (0)6 63 85 29 87
brune.diricq@loreal.com
Christine Burke<\/strong><\/em><\/em>
+33 (0)6 75 54 38 15
christine.burke@loreal.com<\/p>\n

For more information, please contact your bank, broker or financial institution (I.S.I.N. code: FR0000120321), and consult your usual newspapers, the website for shareholders and investors, www.loreal-finance.com or the L\u2019Or\u00e9al Finance app; alternatively, call +33 (0)1 40 14 80 50.
This press release has been secured and authenticated with the blockchain technology.
You can verify its authenticity on the website www.wiztrust.com<\/a><\/p>\n

\n Attachment<\/strong>\n<\/p>\n